Atlas Lithium Hits a Record Milestone with High Grade 5.23% Lithium Oxide Intersect at Only Nine Meters Depth in Its Lithium Project
BOCA RATON, Fla., Jul 13, 2023 - (ACN Newswire) - Atlas Lithium Corporation (NASDAQ: ATLX) ("Atlas Lithium" or "Company"), a leading mineral exploration company, is pleased to announce its new geochemical high mark for lithium mineralization from its ongoing exploration campaign at its Neves Project in Brazil's Lithium Valley. Drill hole DHAB-185 yielded an intersect with 5.23% Li2O mineralization extending from 9.20 to 10.30 meters. According to the Company's technical experts at SGS Canada Inc. ("SGS"), a world leader in mineral resource evaluation, such high grade close to the surface is not common. In aggregate, DHAB-185 showed 21.75 meters at an average grade of 2.12% Li2O. DHAB-185 is located at the new frontier of the ongoing exploration drilling campaign, approximately 650 meters southwest of its Anitta pegmatite trend. This new area is being provisionally referred to as "Anitta 2."
Marc Fogassa, Atlas Lithium's CEO and Chairman, commented, "This result places our Neves Project into the select category of those with encountered lithium mineralization of greater than 5% Li2O. It is rewarding to see the promising results of our exploration campaign such as the discovery of this new ore body."
The Company's exploration program is supervised by a Qualified Person as defined by Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission ("Regulation S-K 1300"). Atlas Lithium has engaged SGS, and in particular, their geologist Marc-Antoine Laporte, a Qualified Person under Regulation S-K 1300, to produce its initial mineral resource estimate report under Regulation SK-1300 for the Company's Neves Project. Mr. Laporte has worked on lithium properties in Brazil's Lithium Valley since 2017.
Figure 1 - Atlas Lithium's Neves Project and additional mineral rights in relation to the areas of Sigma Lithium Corporation, a nearby lithium producer in Brazil's Lithium Valley. Source: Sigma Lithium Corporation public records; Brazilian mining department data.
To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/6706/173391_52a1a3944480fb8c_002full.jpg
Figure 2: DHAB-185 spodumene intersect with lithium mineralization of up to 5.23% Li2O
To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/6706/173391_52a1a3944480fb8c_003full.jpg
Figure 3: DHAB-185 spodumene intersects with lithium mineralization of up to 5.23% Li2O
To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/6706/173391_52a1a3944480fb8c_004full.jpg
About Atlas Lithium Corporation
Atlas Lithium Corporation (NASDAQ: ATLX) is focused on advancing and developing its 100%-owned hard-rock lithium project in Brazil's Lithium Valley, a well-known lithium district in the state of Minas Gerais. The Company's exploration mineral rights for lithium cover approximately 308 km2 and are located primarily in Brazil's Lithium Valley. In addition, Atlas Lithium has 100% ownership of mineral rights for other battery and critical metals including nickel (222 km2), rare earths (122 km2), titanium (89 km2), and graphite (56 km2). The Company also owns approximately 45% of Apollo Resources Corp. (private company; iron) and approximately 28% of Jupiter Gold Corp. (OTCQB: JUPGF) (gold and quartzite).
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are based upon the current plans, estimates and projections of Atlas Lithium Corporation and its subsidiaries (collectively, "Atlas Lithium" or "Company") and are subject to inherent risks and uncertainties which could cause actual results to differ from the forward-looking statements. Such statements include, among others, those concerning market and industry segment growth and demand and acceptance of new and existing products; any projections of production, reserves, sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements regarding future economic conditions or performance; uncertainties related to conducting business in Brazil, as well as all assumptions, expectations, predictions, intentions or beliefs about future events. Therefore, you should not place undue reliance on these forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: results from ongoing geotechnical analysis of projects; business conditions in Brazil; general economic conditions, geopolitical events and regulatory changes; availability of capital; Atlas Lithium's ability to maintain its competitive position; manipulative attempts by short sellers to drive down our stock price; and dependence on key management.
Additional risks related to the Company and its subsidiaries are more fully discussed in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-Q filed with the SEC on May 15, 2023. Please also refer to the Company's other filings with the SEC, all of which are available at www.sec.gov. In addition, any forward-looking statements represent the Company's views only as of today and should not be relied upon as representing its views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements.
Investor Relations: Michael Kim or Brooks Hamilton MZ Group - MZ North America +1 (949) 546-6326 ATLX@mzgroup.us https://www.atlas-lithium.com/ @Atlas_Lithium
Source: Atlas Lithium Corporation Sectors: Metals & Mining, Daily Finance, Daily News
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 Toni Bou Wins 19th Consecutive FIM Trial World Championship Title Sep 08, 2025 18:53 JST
|  Eisai Presents Clinical Study Results of Novel Orexin Receptor Agonist E2086 for Narcolepsy at World Sleep 2025 Sep 08, 2025 17:49 JST
|  Honda to Commercialize UNI-ONE Hands-Free Personal Mobility Device Sep 08, 2025 15:56 JST
|  Mitsubishi Power Signs Contract to Supply Two M701JAC Gas Turbines to O Mon 4 Power Plant Sep 08, 2025 15:36 JST
|  Fujitsu develops generative AI reconstruction technology for optimized and energy-efficient AI models based on Takane LLM Sep 08, 2025 14:28 JST
|  10th anniversary CENTRESTAGE concludes successfully Sep 06, 2025 21:36 JST
|  Mitsubishi Power Receives Contract for Large-Scale GTCC Project with 2,800 MW Total Output for Taiwan's Tung Hsiao Power Plant Sep 05, 2025 21:47 JST
|  Hitachi announces historic $1 billion USD manufacturing investment to power America's energy future through production of critical grid infrastructure Sep 05, 2025 21:00 JST
|  NEC participates in Locked Shields 2025 hosted by the NATO Cooperative Cyber Defence Centre of Excellence Sep 05, 2025 11:20 JST
|  TANAKA Announces Executive Appointment Sep 05, 2025 03:00 JST
|  Honda to Begin Sales of All-new Prelude Sep 04, 2025 13:20 JST
|  Signing of Agreement with Yamaguchi Prefecture and Iwakuni City to Construct Module Pack Plant of Automotive Cylindrical Lithium-Ion Batteries Sep 04, 2025 11:54 JST
|  NEC to begin proof of concept for early earthquake detection and analysis in Colombia Sep 04, 2025 11:15 JST
|  Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025 Sep 04, 2025 10:56 JST
|  Honda Premieres a New Color Option for Four Large-size Outboard Motors at HISWA In-Water Boat Show 2025 in the Netherlands Sep 03, 2025 23:50 JST
|  Toyota Joins TOKYO H2 Project Aiming to Make Tokyo a Global Leader in Hydrogen Sep 03, 2025 22:39 JST
|  Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event Sep 03, 2025 12:30 JST
|  Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status Sep 03, 2025 11:32 JST
|  Anime Tokyo Station: TV Anime "SPY x FAMILY" Special Exhibition, Period: August 16 - November 9, 2025 Sep 03, 2025 11:00 JST
|  Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure Sep 03, 2025 10:58 JST
|
More Latest Release >>
|